Ticker Symbol: KRTX
Karuna Therapeutics Inc
$135.12 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001771917
Company Profile
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.Karuna understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing itsextensive knowledge of neuroscience, the Company is harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: karunatx.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $171.01
Change:
-$5.13
(
-2.91%)
Days Range: $168.24 - $176.35
Beta: 0.95
52wk. High: $245.00
52wk. Low: $158.38
Ytd. Change -15.88%
50 Day Moving Average: $174.49
200 Day Moving Average: $198.12
Shares Outstanding: 37667845
Valuation
Market Cap: 644.2B
PE Ratio: -16.82
EPS (TTM): -10.17
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A